The Biden Administration will make over 170 million doses of the bivalent COVID-19 vaccine booster available to Americans for free at pharmacies, doctor’s offices, health centers, and state and local health departments, the White House announced today. Americans can find local sites administering the vaccine booster here. Once pre-ordered doses are delivered, officials expect over 90% of Americans to have a site within five miles of where they live.

According to the Administration, the Federal Emergency Management Agency will continue to reimburse 90% of eligible costs to set up vaccination sites. The Centers for Medicare & Medicaid Services plans to share information on the new boosters with Medicare enrollees in the coming weeks, and help nursing homes plan to vaccinate residents and staff. In addition, the Department of Health and Human Services will launch a paid media campaign and work with community groups to encourage vaccination.

Among other actions, the Administration plans to purchase 100 million additional at-home COVID-19 tests for the Strategic National Stockpile; add more test-to-treat sites; and eventually transition procurement and distribution of COVID-19 vaccines, tests and treatments to the commercial market.

Related News Articles

Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…
Headline
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine. In addition to ongoing pop-up clinics,…
Headline
Children under age 5 are more likely to receive a COVID-19 vaccine if their parents perceive it as safe and their health care provider recommends it, according…
Headline
AHA this week released a new Thanksgiving-focused toolkit to help promote pediatric COVID-19 vaccination on social media, including sample content and graphics…
Headline
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected…
Headline
Black patients who sought outpatient care for COVID-19 between January and July 2022 were 36% less likely than white patients to receive the antiviral pill…